EUVIMED · CrossrefJournal
Breast Cancer Online
ISSN 1470-9031 · Cambridge University Press (CUP)
Latest articles
Synchronous bilateral invasive breast cancer
Evolution of PBL from normal epithelium to DCIS
The role of aromatase inhibitors as adjuvant therapy in early breast cancer
Principles of preoperative chemotherapy
Mammary stem cells: the root of breast cancer?
Volume–outcome relationships in breast cancer
Safety of breast conservation therapy in BRCA1 and BRCA2 cancers
MRI in familial breast cancer
Update on the importance of parenchymal patterns and breast cancer risk
Impact of altered growth factor signalling on endocrine response in breast cancer and the transition from ER+ to ER− disease
Bisphosphonates and metastasis
Review of: Classification of human breast cancer using gene expression profiling as a component of the survival predictor algorithm
Review of: The expression of ER beta cx in human breast cancer and the relationship to endocrine therapy and survival
Review of: Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma
Review of: Opposing roles for specific TIMPs in breast cancer prognosis
IGF-I; IGF-binding protein-3 and breast cancer risk
Report on Sydney Breast Cancer Trials Symposium: prevention issues
Review of: Demethylation of urokinase promoter as a prognostic marker in patients with breast carcinoma
Review of: Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signalling pathways but not modulation of progesterone receptor activity
Ductal carcinoma in situ of the breast – an overview of the randomized clinical trials
A case study from the Memorial Sloan Kettering Cancer Center: A 40-year-old woman with PET detected mediastinal disease at presentation
Dose-dense chemotherapy: ready for prime time
A case study from the Sunnybrook and Women's College Health Sciences Centre: Do clinical trials of neoadjuvant chemotherapy for locally advanced breast cancer (LABC) overestimate the actual response rates observed in clinical practice?
Prophylactic mastectomy
The role of disseminated and circulating tumour cells in breast cancer
Treating elderly patients with breast cancer
The role of the psychiatrist in the care of women with breast cancer
Bisphosphonates and the prevention of osteoporosis in the adjuvant setting
Surgical considerations for breast-conserving therapy in patients undergoing neoadjuvant chemotherapy for early-stage breast cancer
Update on chemoprevention in BRCA1 and BRCA2 mutation carriers
EUVIMED